XML 95 R76.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2

Investment in Related Party (Details) - Schedule of Investment in Related Party - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Accustem Sciences Inc [Member]
Investment in Related Party (Details) - Schedule of Investment in Related Party [Line Items]
Investment	$ 1,806	$ 2,675
Movement in fair value	(969)	(869)
Total	837	1,806
OKYO Pharma Ltd [Member]
Investment in Related Party (Details) - Schedule of Investment in Related Party [Line Items]
Investment	3,150
Movement in fair value	567
Total	$ 3,717

X

- Definition

Adjustments for gains (losses) arising from a change in the fair value of investment property to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Investment property; Gains (losses) on fair value adjustment, investment property; Profit (loss)]

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IAS
-Number 7
-IssueDate 2023-01-01
-Paragraph 20
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_AdjustmentsForGainsLossesOnFairValueAdjustmentInvestmentProperty
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

The amount of impairment loss on financial assets. [Refer: Financial assets; Impairment loss]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Note Expired 2023-01-01
-Name IFRS
-Number 7
-IssueDate 2023-01-01
-Paragraph 20
-Subparagraph e
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_20_e&doctype=Standard&book=b
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_ImpairmentLossOnFinancialAssets
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The amount of impairment loss recognised in profit or loss for investment property. [Refer: Impairment loss recognised in profit or loss; Investment property]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 40
-IssueDate 2023-01-01
-Paragraph 76
-Subparagraph g
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_76_g&doctype=Standard
-URIDate 2023-03-23

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 40
-IssueDate 2023-01-01
-Paragraph 79
-Subparagraph d
-Clause v
-URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_d_v&doctype=Standard
-URIDate 2023-03-23

+ Details

Name:	ifrs-full_ImpairmentLossRecognisedInProfitOrLossInvestmentProperty
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	tlsa_InvestmentinRelatedPartyDetailsScheduleofInvestmentinRelatedPartyLineItems
Namespace Prefix:	tlsa_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	ifrs-full_CategoriesOfRelatedPartiesAxis=tlsa_AccustemSciencesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_CategoriesOfRelatedPartiesAxis=tlsa_OKYOPharmaLtdMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: